According to Hims & Hers Health's latest financial reports the company has $0.22 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.22 B | 23.02% |
2022-12-31 | $0.17 B | -27.36% |
2021-12-31 | $0.24 B | 146.76% |
2020-12-31 | $0.10 B | 66% |
2019-12-31 | $60.36 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Organovo ONVO | $5.29 M | -97.60% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.12 B | -43.25% | ๐ฌ๐ง UK |
Novavax NVAX | $0.56 B | 157.26% | ๐บ๐ธ USA |
Novocure
NVCR | $0.91 B | 312.08% | Jersey |